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The synthesis of total sulfated glycosaminoglycans (GAG) was stimulated by transforming rowth factors (TGFcl l.Cfold at 5 ng/ml, and TGFDI 
2.05fold at 2.5 ng/ml) in primary cultures of rat liver fat storing cells (FSC). The combination of both TGFs resulted in an additively stimulated 
synthesis of total sulfated GAG (more than 3-fold), chondroitin sulfate (more than &fold) and hyaluronate (3.8fold), respectively, whereas the 
formation of dermatan sulfate was unchanged and that of heparan sulfate was slightly reduced. In summary, TGFs were identified as important 
mediators of stimulated GAG synthesis in those cells of the liver (FSC), which are the primary site of matrix glyc~onjugate production. 
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1. INTRODUCTION 
Fat storing cells (FSC), also termed IT0 cells, play a 
central role in liver fibrogenesis [t-5] since under con- 
ditions of tissue injury FSC proliferate strongly [6,7] 
and transform into myofibroblast-like cells [S] produc- 
ing significant quantities of connective tissue com- 
ponents and, interestingly, a pattern of 
glycosaminoglycans (GAG) and collagen similar to that 
found in the fibrotic liver extracellular matrix [l-5]. 
Studies from others and our laboratory have shown 
recently that secretions of activated Kupffer cells, 
monocytes and platelets stimulate prolifera- 
tion/transformation of FSC in culture [2,7,9] and also 
the synthesis of proteoglycans [2-41 and hyaluronic 
acid (HA) [3,10] by these cells. Until now, little is 
known about the nature of the factors (fibrogenic 
mediators) stimulating FSC. As we could demonstrate 
recently, transforming growth factor LY (TGFcY) 
stimulates FSC proliferation in a dose-dependent man- 
ner [IO]. This effect was inhibited strongly by TGFP 
vol. 
TGFfl regulates cell growth, differentiation and ex- 
tracellular matrix synthesis in a number of cell types 
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~bbrevi~t~o~s~ FSC, fat storing ceiis; TGFo, transforming growth 
factor m; TGF@, transforming growth factor bl; DMEM, Dulbecco’s 
modified Eagles medium; PG, proteoglycans; GAG, 
glycosaminoglycans; CS, chondroitin sulfate; DS, dermatan sulfate; 
HS, heparan sulfate; HA, hyaluronic acid 
(for review see [12]). Preliminary results that (i) TGF;O 
stimulates collagen synthesis in FSC, (ii) in acute 
Ccl,+-induced liver damage the level of TGFP mRNA 
rises [13] and, furthermore, (iii) TGFP gene expression 
is significantly enhanced during active fibrogenesis 
associated with liver disease in man [14] indicate a cen- 
tral role of TGFfl in hepatic fibrogenesis. The purpose 
of the present study was to study the stimulatory poten- 
cy of TGFP and of the mitogen TGFa on FSC ex- 
tracellular sulfated GAG and hyaluronate synthesis. 
Our results indicate that TGFs are potent stimulators of 
an enhanced ~hondroitin sulfate and hyaluronate syn- 
thesis and secretion by FSC. 
2. MATERIALS AND METHODS 
2.1. Materials 
Collagenase H (clostridiopeptidase A, EC 3.4.24.3), trypsin (EC 
3.4.21.4), papain (EC 3.4.22.2) and fetal calf serum were from 
Boehringer Mannheim, FRG. TGF@ (source human platelets) and 
TGFcv (rat r~ombinant) were purchased from ICN Biochemi~als, 
Cleveland, OH, USA. [%]Sulfate (18.5-22.2 GBq/mmol) was from 
New England Nuciear Corp., Boston, MA, USA, D- 
[&‘H]glucosamine hydrochloride (1.48 TBq/mmol) was from Amer- 
sham Buchler GmbH, Braunschweig, FRG, and Nycodenz (analytical 
grade) was from Nyegaard and Co., Oslo, Norway. Calf thymus 
DNA (type I) and pronase were from Sigma Chemical Co., Munich, 
FRC. Chondroitin AC- (EC 4.2.2.5) and -ABC-lyases (EC 4.2.2.4) 
were obtained from Seikagaku Fine Chemicals, Tokyo, Japan. The 
hyaluronate radioligand assay was obtained from Pharmacia, Upp- 
sala, Sweden. 
2.2. Methods 
2.2.1. Cell isolation and cell culture 
Detailed procedures of the isolation and culture of FSC from rats 
have been published previously from this laboratory [2-4,7]. Briefly 
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FSC were isolated by a single-step Nycodenz density gradient (8.2%, 
w/v), seeded with a density of 0.4 x lo6 cells/l0 cm2 on 6-well 
culture plates (Greiner, Niirtingen, FRG) and grown in DMEM (Flow 
Laboratories GmbH, Bonn, FRG) with 4 mmol/l L-glutamine, 
100 kU/l penicillin, 100 mg/l streptomycin and 10% (v/v) fetal calf 
serum in a humidified atmosphere of 5% COa and 95% air at 37°C. 
The purity of the FSC preparations was assessed by light-microscopy 
using the presence of perinucfear lipid droplets, the typical cell shape 
as a marker and by vitamin A-specific autofluorescence. The mean 
purity of freshly isolated cells was more than 85%, cell viability 
assessed by trypan blue exclusion was more than 80%. With the first 
(about 8 h after seeding) and second (about 20 h after seeding) 
medium change most of contaminating cells were removed, and the 
FSC monolayers were essentially free of impurities. With the third 
medium change (about 44 h after seeding) fetal calf serum in DMEM 
was reduced to 0.5% and test substances (TGFa 0.5-50 ng/ml, 
TGFP (0.025-6 ng/ml) were added. Twenty-four hours later growth 
factors were added again during a further medium change whereby 
cultures were labeled with radionuclide. 
2.2.2. Determination of cell proliferation 
DNA measurement: DNA content of the FSC cultures was 
measured fluorometrically using calf thymus DNA as a standard [lS]. 
2.2.3. Determination of the synthesis of total medium proteoglycans 
The synthesis of sulfated GAG was determined by the incorpora- 
tion of [“Slsulfate (18.5-22.2 GBq/mmol; 740 kBq/ml medium) 
during a labeling period of 24 h (details described elsewhere [3,4]). 
Proteoglycans were isolated after solubilization in 7 M urea by bin- 
ding to DEAE-Sephacel (Pharmacia Fine Chemicals, Uppsala, 
Sweden), equilibrated with 0.3 molll sodium acetate buffer (pH 6.6), 
extensively washed with the same buffer, and thereafter eluted using 
2.2 molll NaC1. The radioactivity of an aliquot of the eluate was 
counted by liquid scintillation. Proteoglycan synthesis was expressed 
as radioactivity on the basis of cellular DNA content. 
2.2.4. Determination of specific types of sulfated GAG 
For analysis of specific types of sulfated GAG the DEAE-Sephacel 
h eluate was subjected to consecutive degradation with nitrous acid to 
yield the incorporation of label into heparan sulfate (HS) [16] and to 
enzymatic digestion with chondroitin AC- and -ABC-lyases to obtain 
the fractions of chondroitin 4,dsulfate (CS) and dermatan sulfate 
(DS) [f7], respectively. Analytical details of the method are reported 
elsewhere ]181. 
2.2.5. Determination of hyaluronic acid synthesis 
HA was quantitated according to the method originally described 
by Laurent et al. [19] in a radioligand assay using a specific HA- 
binding protein from bovine cartilage. 
2.2.6. Determination of GAG transport from intracellular to 
extracellular space 
In a pulse-chase xperiment D-[6-3H]glucosamine-labell~ GAG 
were measured in the intracellular space, in the cell surface bound 
fraction and in medium. Control and TGF-treated cells were labelled 
for 3 h with D-[6-‘Hlglucosamine (2600 kBq/culture); thereafter free 
label was removed and the monolayer was washed 3 x with DMEM. 
After 0.5,2.5,7, 14 and 24 h cultures were stopped by aspirating the 
medium (medium fraction) and detaching the cells by mild trypsiniaa- 
tion (0.05Vo (w/v) trypsin, 0.02% (w/v) EDTA) for J-6 min. After 
centrifugation (10 min, 50 x g) FSC were in the pellet and the cell sur- 
face bound fraction in the supernatant. Cells were lysed by repeated 
freezing and thawing. Labelled GAG of the intracellular space, the 
cell surface bound fraction and the medium were determined after 
proteolysis with papain (EC 3.4.22.2) as described previously [4]. 
3. RESULTS 
3.1. Effect of TGFs on FSC proliferation 
Since FSC transform within one week in culture to 
myofibroblast-like cells, the experiments described in 
this report were performed with FSC in primary culture 
within the first days after seeding. Under the described 
conditions monolayers were subconfluent at days 3 and 
4 after seeding but not yet transformed (as assessed by 
actin staining). FSC growth measured by DNA content 
was stimulated slightly by 5 ng/ml TGFcv (1.25-fold of 
control) but inhibited in a dose-dependent manner by 
TGFP (0.72-fold of control at 2.5 nglml TGFP). If 
both factors (20 ng/ml TGF~Y and 0.5 ng/ml TGFP) 
were added together for 48 h DNA content was not 
significantly different from control. 
3.2. TGF stimulated GAG synthesis and transport 
Pulse-chase xperiments with [3H]glucosamine show- 
ed that 0.5 h after pulse in controls 53% of the labelled 
GAG were found in the intracellul~ space whereas the 
membrane bound fraction was 33% and medium frac- 
tion only 14% (fig.1). Within 7 h most of the in- 
tracellularly produced GAG were detected as 
membrane bound (39%) and medium GAGS (51 vo) but 
after 24 h more than 80% of the labelled GAG were 
found in the extracellular space whereas only 5% re- 
mained inside the cell (fig.1). The combination of 
20 ng/ml TGFcv and 0.5 ng/ml TGFP elevated GAG 
synthesis. In TGF-treated cultures 0.5 h after pulse 
most (8 1 To) of the newly synthesized GAGS were found 
intracellularly or membrane bound whereas 24 h later 
only 25% were found intracellularly or cell surface 
bound. The t1/2 of the newly synthesized intracellular 
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Fig. 1. Pulse-chase experiment showing TGF-stimulated GAG 
synthesis and transport to the extracellular D- 
[6-‘HlGlucosamine labelled GAG were measured after prsopf~ysis n
the intracellular space (a), in the cell surface bound fraction (b) and 
in medium (c). The mean values of duplicate experiments are shown. 
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Fig.2. Stimulated incor~ration of jf5S]sulfate into medium GAG of 
FSC. TGFs were added in the presence of 0.5% fetal calf serum on 
the 2nd and 3rd day after seeding. Between the 3rd and 4th culture 
day cells were exposed for 24 h to 740 kBq [35S]sulfate/ml medium. 
Values are expressed as mean rt SD of 4 cultures on the basis of 
DNA. 
GAG decline was similar (about 2.5 h) in controls and 
TGF-treated cultures. The doubling time of medium 
GAG was calculated to be 7 h. 
3.3. TGF-stimulated total surfated medium GAG 
Since, as shown by pulse-chase experiments and 
previous studies [3,4], more than 75% of the newly syn- 
thesized GAG were transported into the extracellular 
space only medium GAG were measured in further ex- 
periments. In the presence of 0.5% fetal calf serum 
TGFcx stimulated medium GAG in a dose-dependent 
manner (fig.2). Maximum stimulation (1 .P-fold per 
culture and 1.4-fold per DNA) was seen at 5 ng/ml 
TGFa. TGFfi too caused a dose-dependent enhanced 
radiosulfate incorporation into secreted GAG with a 
maximal increase of about 2-fold per DNA at 
2.5 ng/ml (fig.2). The combination of TGFa! 
(20 ng/ml) and TGF,& (0.5 nglml) elevated the syn- 
thesis of total medium sulfated GAG more than 3-fold 
compared to control. 
3.4. TGF-stimulated chondroitin &fate synthesis 
In controls (DMEM with 0.5% fetal calf serum) most 
(76%) of the incorporated [3’S]sulfate was found in the 
fraction of DS whereas HS contained 1Wo and CS only 
6% of the radiosulfate (fig.3a). Addition of TGFP 
reduced the relative radiosulfate content of DS from 
76Yo to 58% and HS from 18% to 7%, respectively, 
but increased the relative [35S]sulfate content of CS 
from 6% to 32% (fig.3a). The absolute [3’S]sulfate in- 
corporation into CS expressed as radiosulfate incor- 
poration per DNA was also significantly stimulated by 
TGF@ (at 0.5 ng/ml about 7-fold and at 2.0 ngfml 
more than 8-fold) compared to control (fig.3b). Similar 
but quantitatively lower stimulated CS synthesis was 
136 
b _ 
October 1989 
control TGFa TGF@ TGFa + 
0 5% FCS 20 ng/ml 2 rig/ml TGF$ 
Fig.3. Determination of specific types of sulfated GAG secreted by 
FSC stimulated by TGFs. TCFs were added alone or in combination 
(20 ng/ml TCiFa and 2 ng/ml TGFP) on the 2nd and 3rd day after 
seeding. Between the 3rd and 4th culture day cells were exposed for 
24 h to 740 kBq [35S]sulfate/ml medium. (a) The relative amount of 
specific GAG. (b) Absolute amount of specific GAG. Values are 
expressed as mean f SD of 3 cultures, each with n = 3 on the basis 
of DNA. CS, chondroitin sulfate; DS, dermatan sulfate; HS, 
heparan sulfate. 
seen by adding TGF;w to primary cultures of FSC. The 
combination of TGFa and TGF,& caused a 15-fold 
enhanced CS synthesis whereas DS and HS synthesis 
slightly declined (fig.3b). 
3.4. TGF-stimulated hyaluronate synthesis 
TGFa! (20 ng/ml) and TGFfl(O.5 ng/ml), respective- 
ly, added to FSC cultures stimulated medium HA 
about 2-fold (fig.4b). The dose-response curve of 
TGFP stimulated hyaluronic acid synthesis is shown in 
fig.4a. In combination TGFs (TGFa 20 ng/ml and 
TGF,& 0.5 ng/ml) produced an additive stimulation 
(3.8-fold compared to control) (fig.4b). 
4. DISCUSSION 
In the present study we could demonstrate for the 
first time that beside the effects of TGFs on FSC pro- 
liferation these growth factors significantly stimulate 
GAG synthesis and secretion by these cells. Presently 
the function of the sulfated GAG and other matrix 
elements ecreted by FSC is poorly understood. Several 
authors propose that the interaction of cells with the ex- 
tracellular matrix influences cell behavior affecting cell 
adhesion and motility, growth and differentiation (for 
review see [20]). Important new aspects of the putative 
functions of GAG are coming from observations how- 
ing that type III TGFfl receptor is a membrane- 
integrated hep~an/chondroitin sulfate proteoglycan 
121,221 and that certain GAG act as reservoirs of 
growth factors [23]. However, up to now we are unable 
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Fig.4. Stimulation of hyaluronic acid synthesis and secretion by 
TGFcv and TGFfl. TGFs were added alone and in combination 
(20 ng/ml TGFcr and 0.5 ng/ml TGF#) for 48 h between the 2nd and 
3rd day after seeding. At day 4 cultures were stopped by aspirating 
the medium. DNA was measured in the cell layer and HA was 
estimated in medium by a radioligand assay and expressed on the 
basis of DNA. (a) Dose-response curve of TGFP. (b) Effects of TGFs 
alone and in combination. 
to relate the high output of GAG by FSC to specific 
autocrine or paracrine stimulatory effects. 
In cultured normal human dermal fibroblasts TGFP 
stimulates the synthesis of types I 124,251 and III 1251 
collagens and fibronectin [24-261. In cultured articular 
chondrocytes 1271 and smooth muscle cells [28] TGFP 
stimulates GAG bios~thesis. It is suggested, that 
TGF,& may play a role in normal regulation of ex- 
tracellular matrix production in vivo and may con- 
tribute to the development of skin [25] and organ [29] 
fibrosis. The results that preferentially the synthesis of 
CS is stimulated by TGFP is in agreement with observa- 
tions made by others in mouse mammary epithelial cells 
[20] and smooth muscle cells [30]. Further observations 
that (i) TGFP is a potent chemoattractant for 
peripheral blood monocytes 1311 and fibroblasts [33], 
(ii) TGFP increases cell motility f34], and (iii) TGF,& 
reduces extracellul~ protease activity [34] may also be 
significant in fibrogenesis. 
In conclusion, the results obtained lead us to suggest 
that both TGFa and TGFB may be candidate mediators 
of fibrogenic activity in culture but also in vivo during 
hepatic injury. Their concerted action of FSC might be 
of significance for the strong accumulation of CS and 
HA in the extracellular matrix of fibrotic livers. 
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